NuVasive Inc.'s screw products infringe five of a surgeon and inventor’s spinal-implant patents, a Delaware federal jury said ...

Spinal fusion is recommended for patients with low ... spinal fusion/laminectomy or vertebroplasty overuse." For example, NuVasive and Medtronic paid physicians $8 million and $7.5 million ...

Mr. Valentine has over thirty years of executive leadership and commercialization success at high-performing, growth-stage ...

NuVasive also develops biologics used to aid in the spinal fusion or bone-healing processes, such as a collagen-based synthetic bone substitute and synthetic bone-graft material. NuVasive ...

joint fusion, osteotomy and arthrodesis. Over the past three months, shares of GMED have gained 24.3% compared with the industry’s 0.2% growth. The company is benefiting from NuVasive business ...

Market OverviewThe global Bone Graft Substitutes Market is valued at USD 4.04 Billion in 2024 and is projected to reach a ...

The Spinal Interbody Fusion Market is a critical segment of the orthopedic and neurosurgical medical device industry, focusing on the treatment of spinal disorders through surgical intervention.

With this approval, the Catamaran is now indicated to treat the SI joint as either a stand-alone treatment or to augment a spinal fusion. "The FDA has cleared the Catamaran SI Joint Fusion System ...

After starting his career holding numerous roles with increasing levels of responsibility at Medtronic Spine and Biologics, he was a senior executive at NuVasive from 2001 until 2015. Mr ...